References: A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
September 2021.
References 1 VestergaardP
40 The period of reduced appetite and food noise provides an excellent opportunity to cultivate these mindful habits
In most cases, the symptoms improve as the body adjusts to the medication
While these mechanisms effectively lower blood glucose and promote weight loss, they also create physiological changes that can impact fluid and electrolyte homeostasis